Skip to main content
Have a personal or library account? Click to login
Optimal Care Pathways for People with Lung Cancer- a Scoping Review of the Literature Cover

Optimal Care Pathways for People with Lung Cancer- a Scoping Review of the Literature

Open Access
|Sep 2020

References

  1. Australian Institute of Health and Welfare. Australia’s health 2016. Canberra, ACT: AIHW; 2016. [cited 18 May 2019] Availabe from: https://www.aihw.gov.au/getmedia/9844cefb-7745-4dd8-9ee2-f4d1c3d6a727/19787-AH16.pdf.aspx?inline=true.
  2. Hermens RPMG, Ouwens MMTJ, Vonk-Okhuijsen SY, van der Wel Y, Tjan-Heijnen VCG, van den Broek LD, et al. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: A first step toward implementing a multidisciplinary, evidence-based guideline. Lung Cancer, 2006; 54(1): 117124. DOI: 10.1016/j.lungcan.2006.07.001
  3. Barrett J, Hamilton W. Pathways to the diagnosis of lung cancer in the UK: a cohort study. BMC Family Practice, 2008; 9(1). DOI: 10.1186/1471-2296-9-31
  4. Hall SE, Holman CD, Sheiner H. The influence of socio-economic and locational disadvantage on patterns of surgical care for lung cancer in Western Australia 1982–2001. Australian Health Review, 2004; 27(2): 6879. DOI: 10.1071/AH042720068
  5. Verma R, Pathmanathan S, Otty Z, Binder J, Vangaveti V, Buttner P, et al. Delays in lung cancer referral pathways between rural and urban patients in North Queensland: A mixed methods study. Internal Medicine Journal, 2018; 48(10): 12281233. DOI: 10.1111/imj.13934
  6. Evans JM, Matheson G, Buchman S, MacKinnon M, Meertens E, Ross J, et al. Integrating cancer care beyond the hospital and across the cancer pathway: a patient-centred approach. Healthcare Quarterly, 2015; 17(Special Issue): 2832. DOI: 10.12927/hcq.2014.24006
  7. Forrest LF, Sowden S, Rubin G, White M, Adams J. Socio-economic inequalities in patient, primary care, referral, diagnostic, and treatment intervals on the lung cancer care pathway: protocol for a systematic review and meta-analysis. Systematic Reviews, 2014; 3(30). DOI: 10.1186/2046-4053-3-30
  8. Doolittle GC, Spaulding AO. Providing access to oncology care for rural patients via telemedicine. Journal of Oncology Practice, 2006; 2(5): 228230. DOI: 10.1200/jop.2006.2.5.228
  9. Sabesan S, Larkins S, Evans R, Varma S, Andrews A, Beuttner P, et al. Telemedicine for rural cancer care in North Queensland: bringing cancer care home. Australian Journal of Rural Health, 2012; 20(5): 259264. DOI: 10.1111/j.1440-1584.2012.01299.x
  10. Underhill C, Bartel R, Goldstein D, Snodgrass H, Begbie S, Yates P, et al. Mapping oncology services in regional and rural Australia. Australian Journal of Rural Health, 2009; 17(6): 321329. DOI: 10.1111/j.1440-1584.2009.01106.x
  11. Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: A multidisciplinary review. BMJ, 327(7425): 12191221. DOI: 10.1136/bmj.327.7425.1219
  12. Trosman JR, Carlos RC, Simon MA, Madden DL, Gradishar WJ, Benson AB, et al. Care for a patient with cancer as a project: management of complex task interdependence in cancer care delivery. Journal of Oncology Practice, 2016; 12(11): 11011113. DOI: 10.1200/JOP.2016.013573
  13. Wodchis WP, Arthurs E, Khan AI, Gandhi S, MacKinnon M, Sussman J. Cost trajectories for cancer patients. Current Oncology, 2016; 23(Suppl 1): S64S75. DOI: 10.3747/co.23.2995
  14. Jensen KH, Maina PJ. Cancer pathways are associated with improved long-term survival. Danish Medical Journal, 2015; 62(2).
  15. Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ, 1998; 316(7125): 133137. DOI: 10.1136/bmj.316.7125.133
  16. Mur-Veeman I, Hardy B, Steenbergen M, Wistow G. Development of integrated care in England and the Netherlands: managing across public-private boundaries. Health Policy, 2003; 65(3): 22741. DOI: 10.1016/S0168-8510(02)00215-4
  17. Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. Journal of Clinical Oncology, 2001; 19(11): 28862897. DOI: 10.1200/JCO.2001.19.11.2886
  18. Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. Thorax, 1998; 53(S1): S18. DOI: 10.1136/thx.53.suppl_1.S1
  19. Kinsman L, Rotter T, James E, Snow P, Willis J. What is a clinical pathway? Development of a definition to inform the debate. BMC Medicine, 2010; 8(31). DOI: 10.1186/1741-7015-8-31
  20. Cancer Council Australia. Optimal care pathway for people with lung cancer. Australia: Cancer Council Australia; 2016 [cited 23 March 2019]. Available from: https://www.cancer.org.au/content/ocp/health/optimal-care-pathway-for-people-with-lung-cancer-june-2016.pdf.
  21. De Bleser L, Depreitere R, De Waele K, Vanhaecht K, Vlayen J, Sermeus W. Defining pathways. Journal of Nursing Management, 2006; 14(7): 55363. DOI: 10.1111/j.1365-2934.2006.00702.x
  22. Khan AI, Arthurs E, Gradin S, MacKinnon M, Sussman J, Kukreti V. Integrated care planning for cancer patients: a scoping review. International Journal of Integrated Care, 2017; 17(6): 55. DOI: 10.5334/ijic.2543
  23. Coory MD, Green AC, Stirling J, Valery PC. Survival of Indigenous and non-Indigenous Queenslanders after a diagnosis of lung cancer: a matched cohort study. Medical Journal of Australia, 2008; 188(10): 562566. DOI: 10.5694/j.1326-5377.2008.tb01790.x
  24. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology, 2005; 8(1): 1932. DOI: 10.1080/1364557032000119616
  25. Cancer Care Ontario. Lung cancer pathway map. Ontario: Ontario Health; 2019. [cited 12 Feb 2019] Available from: https://www.cancercareontario.ca/en/pathway-maps/lung-cancer.
  26. Hillerdal G. Recommendations from the Swedish Lung Cancer Study group: Shorter waiting times are demanded for quality in diagnostic work-ups for lung care. Swedish Medical Journal, 1999; 96(4691).
  27. Lung Clinical Expert Group. National Optimal Lung Cancer Pathway and implementation guide. London: NHS; 2017. [cited 17 February 2019]. Available from: https://www.cancerresearchuk.org/sites/default/files/national_optimal_lung_pathway_aug_2017.pdf.
  28. United Kingdom Lung Cancer Coalition. Millimetres matter: Implementing the national optimal lung cancer pathway. UK:United Kingdom Lung Cancer Coalition; 2018. [cited 3 March 2019]. Available from: https://mediaserver.responsesource.com/press-release/114156/mm_matter_embargo.pdf.
  29. Fung-Kee-Fung M, Maziak DE, Pantarotto JR, Smylie J, Taylor L, Timlin T, et al. Regional process redesign of lung cancer care: a learning health system pilot project. Current Oncology, 2018; 25(1): 5966. DOI: 10.3747/co.25.3719
  30. Aasebo U, Strom HH, Postmyr M. The Lean method as a clinical pathway facilitator in patients with lung cancer. Clinical Respiratory Journal, 2012; 6(3): 16974. DOI: 10.1111/j.1752-699X.2011.00271.x
  31. Ellis PG. Development and implementation of oncology care pathways in an integrated care network: the Via Oncology Pathways experience. Journal of Oncology Practice, 2013; 9(3): 1713. DOI: 10.1200/JOP.2013.001020
  32. Evans WK, Ung YC, Assouad N, Chyjek A, Sawka C. Improving the quality of lung cancer care in Ontario: the lung cancer disease pathway initiative. Journal of Thoracic Oncology, 2013; 8(7): 87682. DOI: 10.1097/JTO.0b013e31828cb548
  33. Fasola G, Menis J, Follador A, De Carlo E, Valent F, Aresu G, et al. Integrated care pathways in lung cancer: a quality improvement project. International Journal of Technology Assessment in Health Care, 2018; 34(1): 39. DOI: 10.1017/S026646231700441X
  34. Hagglund M, Bolin P, Koch S. Living with lung cancer–Patients’ experiences as input to ehealth service design. Studies in health technology and informatics, 2015; 216: 391395.
  35. Jiang T, Ren S, Li X, Su C, Zhou C, O’Brien M. The changing diagnostic pathway for lung cancer patients in Shanghai, China. European Journal of Cancer, 2017; 84: 168172. DOI: 10.1016/j.ejca.2017.07.036
  36. Kedia SK, Ward KD, Digney SA, Jackson BM, Nellum AL, McHugh L, et al. ‘One-stop shop’: lung cancer patients’ and caregivers’ perceptions of multidisciplinary care in a community healthcare setting. Translational Lung Cancer Research, 2015; 4(4): 45664.
  37. Kaltenthaler E, McDonnell A, Peters J. Monitoring the care of lung cancer patients: linking audit and care pathways. Journal of Evaluation in Clinical Practice, 2001; 7(1): 1320. DOI: 10.1046/j.1365-2753.2001.00275.x
  38. Fasola G, Rizzato S, Merlo V, Aita M, Ceschia T, Giacomuzzi F, et al. Adopting integrated care pathways in non-small-cell lung cancer: from theory to practice. Journal of Thoracic Oncology, 2012; 7(8): 128390. DOI: 10.1097/JTO.0b013e318257fbfe
  39. Jackman DM, Zhang Y, Dalby C, Nguyen T, Nagle J, Lydon CA, et al. Cost and survival analysis before and after implementation of Dana-Farber Clinical Pathways for Patients with Stage IV Non–Small-Cell Lung Cancer. Journal of Oncology Practice, 2017; 13(4): e346e352. DOI: 10.1200/JOP.2017.021741
  40. Neubauer MA, Hoverman JR, Kolodziej M, Reisman L, Gruschkus SK, Hoang S, et al. Cost effectiveness of evidence-based treatment guidelines for the treatment of non–small-cell lung cancer in the community setting. Journal of Oncology Practice, 2010; 6(1): 1218. DOI: 10.1200/JOP.091058
  41. Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. Journal of the National Cancer Institute, 2017; 109(9): 1. DOI: 10.1093/jnci/djx029
  42. Manley S, Delaney L. Lung Cancer Pathways Project: local referral and diagnostic pathway implementation for lung cancer NNSW LHD pilot site. In: Innovations in Cancer Treatment and Care Conference; 2015; Sydney, Australia. Cancer Institute NSW; 2015. [cited 17 March 2019]. Available from: https://www.cancer.nsw.gov.au/about-us/events/innovations-in-cancer-treatment-and-care/past-conferences/abstracts/lung-cancer-pathways-project-local-referral-and-d.
  43. Bennett A, Patrick C. The value of the lung cancer nurse specialist in the development and implimentation of the local optimal lung cancer pathway. Lung Cancer, 2019; 127(Supplement 1): S51. DOI: 10.1016/S0169-5002(19)30166-7
  44. Bakewell F, Hodgkiss M, Perumpalath B, Wright-Morris D, Severn H, Anwar S. National Optimal Lung Cancer Pathway: implementation of a ‘straight to CT’ pathway at NUH. Lung Cancer, 2019; 127: S13S14. DOI: 10.1016/S0169-5002(19)30074-1
  45. Woznitza N, Devaraj A, Janes SM, Duffy SW, Bhowmik A, Rowe S, et al. Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial. Trials, 2017; 18(1): 521. DOI: 10.1186/s13063-017-2268-x
  46. Lloyd KL, Rice A, Robertus JL, Brambilla C, Popat S, Kemp S, et al. National Optimal Lung Cancer Pathway implementation: can pathologists comply with turnaround times? Lung Cancer, 2019; 127: S3S4. DOI: 10.1016/S0169-5002(19)30052-2
  47. ACE Lung Cancer Pathway Cluster. Improving diagnostic pathways for patients with suspected lung cancer: Final report. UK: Acelerate, Coordinate, Evaluate Programme; 2017. [cited 21 March 2019]. Available from: https://www.macmillan.org.uk/_images/ACE-Lung-Pathways-final-report-v1_tcm9-310170.pdf.
  48. Rizzato S, Merlo V, Aita M, Sibau A, Menis J, Gurrieri L, et al. Integrated care pathways (ICPs) for non-small cell lung cancer (NSCLC) patients (Pts): A multidisciplinary quality improvement project. Journal of Clinical Oncology, 2011; 29(15_suppl): e16573e16573. DOI: 10.1200/jco.2011.29.15_suppl.e16573
  49. Kim ML, Matheson L, Garrard B, Francis M, Broad A, Malone J, et al. Use of clinical quality indicators to improve lung cancer care in a regional/rural network of health services. Australian Journal of Rural Health, 2019; 27(2): 183187. DOI: 10.1111/ajr.12493
  50. Moneke J, Khan S, Hussain I. Implementation of National Optimal Lung Cancer Pathway: an early experience. Lung Cancer, 2019; 127: S11S12. DOI: 10.1016/S0169-5002(19)30070-4
  51. Kutubudin K, Robinson R, Deus P, Hughes K, Wight AG. Impact of national optimal lung cancer pathway – can we meet the 28 day standard by 2020? Thorax, 2018; 73(Suppl 4): 71. DOI: 10.1136/thorax-2018-212555.229
  52. Shamji FM, Deslauriers J. Fast-tracking investigation and staging of patients with lung cancer. Thoracic Surgery Clinics, 2013; 23(2): 18791. DOI: 10.1016/j.thorsurg.2013.01.012
  53. Bravi F, Ruscio ED, Frassoldati A, Cavallesco GN, Valpiani G, Ferrozzi A, et al. Patient and health care professional perspectives: a case study of the lung cancer integrated care pathway. International Journal of Integrated Care, 2018; 18(4): 7. DOI: 10.5334/ijic.3972
  54. McDowell G, O’Rourke N, Lumsden G, Cameron E. Improving lung cancer outcomes in the West of Scotland. Lung Cancer, 2017; 83(Supplement 1): S49S50. DOI: 10.1016/S0169-5002(14)70136-9
  55. Fuller L, Robson S, Tasker C. Implementing the optimal lung cancer pathway: climbing out of the ‘too hard’ pile, in Northern Cancer Alliance. Collaborating to improve cancer care conference proceedings; 2017.
  56. Jacobsen MM, Silverstein SC, Quinn M, Waterston LB, Thomas CA, Benneyan JC, et al. Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review. Lung Cancer, 2017; 112: 156164. DOI: 10.1016/j.lungcan.2017.08.011
  57. NHS England. Implementing a timed lung cancer diagnostic pathway: A handbook for local health and care systems. NHS Rapid cancer diagnostic and assessment pathways. London: NHS; 2018. [cited 3 Mar 2019]. Available from: https://www.england.nhs.uk/wp-content/uploads/2018/04/implementing-timed-lung-cancer-diagnostic-pathway.pdf.
  58. Malalasekera A, Nahm S, Blinman PL, Kao SC, Dhillon HM, Vardy JL. How long is too long? A scoping review of health system delays in lung cancer. European Respiratory Review, 2018; 27(149). DOI: 10.1183/16000617.0045-2018
  59. Cassim S, Chepulis L, Keenan R, Kidd J, Firth M, Lawrenson R. Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review. BMC Cancer, 2019; 19(1): 25. DOI: 10.1186/s12885-018-5169-9
  60. Ouwens M, Hermens R, Hulscher M, Vonk-Okhuijsen S, Tjan-Heijnen V, Termeer R, et al. Development of indicators for patient-centred cancer care. Support Care Cancer, 2010; 18(1): 12130. DOI: 10.1007/s00520-009-0638-y
DOI: https://doi.org/10.5334/ijic.5438 | Journal eISSN: 1568-4156
Language: English
Submitted on: Oct 12, 2019
Accepted on: Sep 8, 2020
Published on: Sep 28, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Zulfiquer Otty, Amy Brown, Sabe Sabesan, Rebecca Evans, Sarah Larkins, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.